US Retail Drug Spending Growth Accelerates In 2019, Driven Mostly By Utilization, Not Prices
Executive Summary
Price growth for brands slowed in 2019 and rebates increased at the lowest rate since 2012, the latest CMS National Health Expenditures Report finds.